The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent. This represents a rising precision medicine field with great promise for preventing and treating many intractable or genetic diseases. In addition, in vitro transcribed mRNA has achieved programmed production, which is more effective, faster in design and production, as well as more flexible and cost-effective than conventional approaches that may offer. Based on these extraordinary advantages, mRNA vaccines have the characteristics of the swiftest response to large-scale outbreaks of infectious diseases, such as the currently devastating pandemic COVID-19. It has always been the scientists’ desire to improve the stability, immunogenicity, translation efficiency, and delivery system to achieve efficient and safe delivery of mRNA. Excitingly, these scientific dreams have gradually been realized with the rapid, amazing achievements of molecular biology, RNA technology, vaccinology, and nanotechnology. In this review, we comprehensively describe mRNA-based therapeutics, including their principles, manufacture, application, effects, and shortcomings. We also highlight the importance of mRNA optimization and delivery systems in successful mRNA therapeutics and discuss the key challenges and opportunities in developing these tools into powerful and versatile tools to combat many genetic, infectious, cancer, and other refractory diseases.

Binary transition metal oxides have been attracting extensive attention as promising anode materials for lithium-ion batteries, due to their high theoretical specific capacity, superior rate performance and good cycling stability. Here, loaf-like ZnMn2O4 nanorods with diameters of 80-150 nm and lengths of several micrometers are successfully synthesized by annealing MnOOH nanorods and Zn(OH)2 powders at 700 °C for 2 h. The electrochemical properties of the loaf-like ZnMn2O4 nanorods as an anode material are investigated in terms of their reversible capacity, and cycling performance for lithium ion batteries. The loaf-like ZnMn2O4 nanorods exhibit a reversible capacity of 517 mA h g(-1) at a current density of 500 mA g(-1) after 100 cycles. The reversible capacity of the nanorods still could be kept at 457 mA h g(-1) even at 1000 mA g(-1). The improved electrochemical performance can be ascribed to the one-dimensional shape and the porous structure of the loaf-like ZnMn2O4 nanorods, which offers the electrode convenient electron transport pathways and sufficient void spaces to tolerate the volume change during the Li(+) intercalation. These results suggest the promising potential of the loaf-like ZnMn2O4 nanorods in lithium-ion batteries.

No abstract